Results 21 to 30 of about 461,819 (327)

Ozanimod: A Review in Ulcerative Colitis

Drugs, 2022
Ozanimod (Zeposia®) is the first sphingosine-1-phosphate receptor (S1PR) modulator to be approved for the treatment of adults with moderately to severely active ulcerative colitis in the USA, and in adults with moderately to severely active ulcerative ...
J. Paik
semanticscholar   +1 more source

Atherosclerotic Cardiovascular Disease in Inflammatory Bowel Disease: The Role of Chronic Inflammation and Platelet Aggregation

Medicina, 2023
Background and Objectives: Atherosclerosis is one of inflammatory bowel disease’s most significant cardiovascular manifestations. This research aimed to examine the relationship between biochemical, haemostatic, and immune parameters of atherosclerosis ...
Sofija I. Lugonja, Ivana L. Pantic, Tamara M. Milovanovic, Vesna M. Grbovic, Bojana M. Djokovic, Željko D. Todorovic, Stefan M. Simovic, Raša H. Medovic, Nebojsa D. Zdravkovic, Natasa D. Zdravkovic   +9 more
doaj   +1 more source

Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study [PDF]

Intestinal Research, 2023
Background/Aims We conducted a nationwide population-based study to investigate incidence rates of colorectal and biliary cancers according to accompanying primary sclerosing cholangitis in Korean ulcerative colitis patients.
Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park   +5 more
doaj   +1 more source

Ulcerative colitis: an update.

Clinical medicine (London), 2021
Ulcerative colitis is a relapsing and remitting disease that is increasing in incidence and prevalence. Management aims to achieve rapid resolution of symptoms, mucosal healing and improvement in a patient's quality of life.
J. Segal, J. LeBlanc, A. Hart
semanticscholar   +1 more source

Acute pulmonary embolism following corticosteroid administration in acute severe ulcerative colitis with gastrointestinal bleeding: A case report

Frontiers in Cardiovascular Medicine, 2022
BackgroundUlcerative colitis often leads to gastrointestinal bleeding and venous thromboembolism (VTE). At present, there is no clear conclusion about anticoagulant therapy for these patients.
Xuhan Liu, Xia Peng, Chunyan Rong, Weihua Zhang   +3 more
doaj   +1 more source

Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.

PLoS ONE, 2021
The burden of inflammatory bowel disease (IBD) in Australia is increasing but national data about the current prevalence are limited. We aimed to estimate the prevalence of IBD (including Crohn's disease, ulcerative colitis and unspecified IBD) as well ...
Doreen Busingye, Allan Pollack, Kendal Chidwick   +2 more
doaj   +1 more source

[Ulcerative colitis]. [PDF]

Recenti progressi in medicina, 2016
Inflammatory bowel disease (IBD), such as Crohn's disease (CD) and ulcerative colitis (UC), are chronic, relapsing inflammatory disorders of the digestive tract resulting from dysregulated immune responses toward environmental factors in genetically predisposed individuals.
Lopetuso, Loris Riccardo, Gasbarrini, Antonio   +1 more
openaire   +4 more sources

Colitis due to Cytomegalovirus and Herpes Simplex Type 2 as a Complication of a First Presentation of Inflammatory Bowel Disease

GE: Portuguese Journal of Gastroenterology, 2021
Introduction: The first presentation of ulcerative colitis may be an acute flare in about 15% of patients, requiring hospital admission. In acute severe steroid-refractory ulcerative colitis, cytomegalovirus (CMV) should be sought because it is a ...
Tiago Leal, Bruno Arroja, Dalila Costa, Carla Ferreira, João Bruno Soares, Raquel Gonçalves   +5 more
doaj   +1 more source

Anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: Potential clinical value [PDF]

, 2002
Anti-Saccharomyces cerevisiae antibodies (ASCA) have been described as specific markers in Crohn's disease and their healthy first-degree relatives. 171 patients with Crohn's disease, their 105 first-degree relatives, 145 patients with ulcerative colitis
Folwaczny, Christian, Glas, J., Herbinger, K. H., Hoelscher, Michael, Török, H.-P., Vilsmaier, F.   +5 more
core   +1 more source

Investigating the Mechanisms of Bisdemethoxycurcumin in Ulcerative Colitis: Network Pharmacology and Experimental Verification

Molecules, 2022
Ulcerative colitis is a chronic inflammatory bowel disorder that is hard to cure once diagnosed. Bisdemethoxycurcumin has shown positive effects on inflammatory diseases.
Huihuan Wu, Sha Tu, Zewei Zhuo, Rui Jiang, Ruijie Zeng, Qi Yang, Qizhou Lian, Weihong Sha, Hao Chen   +8 more
doaj   +1 more source